speb/financial-data huggingface dataset:
RGCO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 557540.00
RGCO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 692421.00
RGCO balance_sheet (quarterly, 2026-03-31) — Other Payable: 129307.00
RGCO income_statement (quarterly, 2026-03-31) — Other Taxes: 866570.00
RGCO balance_sheet (quarterly, 2026-03-31) — Payables: 10178970.00
RGCO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 13896930.00
RGCO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
RGCO balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 0.00
RGCO income_statement (quarterly, 2026-03-31) — Pretax Income: 11294524.00
RGCO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -188276.00
RGCO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -4169255.00
RGCO balance_sheet (quarterly, 2026-03-31) — Receivables: 13106061.00
RGCO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 30235384.00
RGCO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 3071105.00
RGCO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -31204836.00
RGCO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 21391030.00
RGCO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 28905.00
RGCO balance_sheet (quarterly, 2026-03-31) — Share Issued: 10405811.00
RGCO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 373984.00
RGCO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 124084505.00
RGCO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 124084505.00
RGCO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
RGCO income_statement (quarterly, 2026-03-31) — Tax Provision: 2550034.00
RGCO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.23
RGCO balance_sheet (quarterly, 2026-03-31) — Total Assets: 337104818.00
RGCO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 253010045.00
RGCO balance_sheet (quarterly, 2026-03-31) — Total Debt: 147113427.00
RGCO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 124084505.00
RGCO income_statement (quarterly, 2026-03-31) — Total Expenses: 34173059.00
RGCO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 213020313.00
RGCO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 311392134.00
RGCO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 175685583.00
RGCO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 11283950.00
RGCO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1787958.00
RGCO balance_sheet (quarterly, 2026-03-31) — Working Capital: -11622046.00
RGEN cash_flow (annual, 2021-12-31) — Common Stock Issuance: 0.00
RGEN balance_sheet (annual, 2021-12-31) — Current Debt: 255258000.00
RGEN balance_sheet (annual, 2021-12-31) — Foreign Currency Translation Adjustments: -16886000.00
RGEN cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 16515000.00
RGEN cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 1066000.00
RGEN cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
RGEN cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: -21000.00
RGEN cash_flow (annual, 2021-12-31) — Operating Gains Losses: 13000.00
RGEN balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 255258000.00
RGEN cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -21000.00
RGEN income_statement (annual, 2022-12-31) — +Operating Expense: 259765000.00
RGEN income_statement (annual, 2022-12-31) — +Total Revenue: 801536000.00
RGEN balance_sheet (annual, 2022-12-31) — Accounts Payable: 27554000.00
RGEN balance_sheet (annual, 2022-12-31) — Accounts Receivable: 116247000.00
RGEN balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -92307000.00
RGEN balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1547266000.00
RGEN balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -1365000.00
RGEN income_statement (annual, 2022-12-31) — Basic Average Shares: 55460232.00
RGEN income_statement (annual, 2022-12-31) — Basic EPS: 3.35
RGEN cash_flow (annual, 2022-12-31) — Beginning Cash Position: 603814000.00
RGEN balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1599000.00
RGEN cash_flow (annual, 2022-12-31) — Capital Expenditure: -133346000.00
RGEN cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -3512000.00
RGEN balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 138346000.00
RGEN balance_sheet (annual, 2022-12-31) — Capital Stock: 556000.00
RGEN balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 523458000.00
RGEN balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 623757000.00
RGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -13337000.00
RGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -233236000.00
RGEN cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 172083000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Account Payable: -8197000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -2019000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Inventory: -57204000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -231000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -987000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Payable: -8197000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -10216000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 2396000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Receivables: -3596000.00
RGEN cash_flow (annual, 2022-12-31) — Change In Working Capital: -69838000.00
RGEN cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -3596000.00
RGEN cash_flow (annual, 2022-12-31) — Changes In Cash: -74490000.00
RGEN balance_sheet (annual, 2022-12-31) — Common Stock: 556000.00
RGEN balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1910700000.00
RGEN cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
RGEN cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
RGEN balance_sheet (annual, 2022-12-31) — Construction In Progress: 31553000.00
RGEN income_statement (annual, 2022-12-31) — Cost Of Revenue: 345830000.00
RGEN balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 15856000.00
RGEN balance_sheet (annual, 2022-12-31) — Current Assets: 998118000.00
RGEN balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 6957000.00
RGEN balance_sheet (annual, 2022-12-31) — Current Debt: 284615000.00
RGEN balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 291572000.00
RGEN balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 19283000.00
RGEN balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 19283000.00
RGEN balance_sheet (annual, 2022-12-31) — Current Liabilities: 404196000.00
RGEN cash_flow (annual, 2022-12-31) — Deferred Income Tax: -1352000.00
RGEN cash_flow (annual, 2022-12-31) — Deferred Tax: -1352000.00
RGEN cash_flow (annual, 2022-12-31) — Depreciation: 57012000.00
RGEN cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 57012000.00
RGEN cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 57012000.00
RGEN income_statement (annual, 2022-12-31) — Diluted Average Shares: 57455275.00
RGEN income_statement (annual, 2022-12-31) — Diluted EPS: 3.24
RGEN income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 185959000.00
RGEN income_statement (annual, 2022-12-31) — EBIT: 220302000.00
RGEN income_statement (annual, 2022-12-31) — EBITDA: 277314000.00
RGEN cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -5866000.00
RGEN cash_flow (annual, 2022-12-31) — End Cash Position: 523458000.00
RGEN cash_flow (annual, 2022-12-31) — Financing Cash Flow: -13337000.00
RGEN balance_sheet (annual, 2022-12-31) — Finished Goods: 82656000.00
RGEN balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -34394000.00
RGEN cash_flow (annual, 2022-12-31) — Free Cash Flow: 38737000.00
RGEN cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
RGEN income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 6978000.00
RGEN balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -34394000.00
RGEN balance_sheet (annual, 2022-12-31) — Goodwill: 855513000.00
RGEN balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 1216131000.00
RGEN balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 117612000.00
RGEN balance_sheet (annual, 2022-12-31) — Gross PPE: 408003000.00
RGEN income_statement (annual, 2022-12-31) — Gross Profit: 455706000.00
RGEN cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 34365000.00
RGEN balance_sheet (annual, 2022-12-31) — Income Tax Payable: 2459000.00
RGEN income_statement (annual, 2022-12-31) — Interest Expense: 1162000.00
RGEN income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1162000.00
RGEN cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 1033000.00
RGEN balance_sheet (annual, 2022-12-31) — Inventory: 238277000.00
RGEN balance_sheet (annual, 2022-12-31) — Invested Capital: 2195315000.00
RGEN cash_flow (annual, 2022-12-31) — Investing Cash Flow: -233236000.00
RGEN cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
RGEN cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
RGEN balance_sheet (annual, 2022-12-31) — Land And Improvements: 1003000.00
RGEN balance_sheet (annual, 2022-12-31) — Leases: 115672000.00
RGEN balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 131389000.00
RGEN balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 131389000.00
RGEN cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
RGEN cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
RGEN balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 38120000.00
RGEN cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
RGEN cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
RGEN income_statement (annual, 2022-12-31) — Net Income: 185959000.00
RGEN income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 185959000.00
RGEN income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 185959000.00
RGEN income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 185959000.00
RGEN income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 185959000.00
RGEN cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 185959000.00
RGEN income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 185959000.00
RGEN cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -45000000.00
RGEN income_statement (annual, 2022-12-31) — Net Interest Income: -2977000.00
RGEN cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -100000000.00
RGEN cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
RGEN cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
RGEN income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -2977000.00
RGEN cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -17044000.00
RGEN cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 110000.00
RGEN balance_sheet (annual, 2022-12-31) — Net PPE: 315696000.00
RGEN cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -84834000.00
RGEN balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 694569000.00
RGEN balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 840000.00
RGEN balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 23000000.00
RGEN balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 840000.00
RGEN balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 23000000.00
RGEN income_statement (annual, 2022-12-31) — Normalized EBITDA: 241607000.00
RGEN income_statement (annual, 2022-12-31) — Normalized Income: 155643757.00
RGEN cash_flow (annual, 2022-12-31) — Operating Cash Flow: 172083000.00
RGEN income_statement (annual, 2022-12-31) — Operating Income: 195941000.00
RGEN income_statement (annual, 2022-12-31) — Operating Revenue: 801536000.00
RGEN balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 55557698.00
RGEN balance_sheet (annual, 2022-12-31) — Other Current Assets: 17409000.00
RGEN balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 284615000.00
RGEN balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 13950000.00
RGEN balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -34394000.00
RGEN income_statement (annual, 2022-12-31) — Other Income Expense: 26176000.00
RGEN balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 360618000.00
RGEN cash_flow (annual, 2022-12-31) — Other Non Cash Items: -27014000.00
RGEN balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 815000.00
RGEN balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 62315000.00
RGEN income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -9531000.00
RGEN balance_sheet (annual, 2022-12-31) — Other Properties: 220056000.00
RGEN balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 100299000.00
RGEN balance_sheet (annual, 2022-12-31) — Payables: 30013000.00
RGEN balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 45869000.00
RGEN balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 33522000.00
RGEN balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
RGEN balance_sheet (annual, 2022-12-31) — Prepaid Assets: 2428000.00
RGEN income_statement (annual, 2022-12-31) — Pretax Income: 219140000.00
RGEN cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 3707000.00
RGEN balance_sheet (annual, 2022-12-31) — Properties: 0.00
RGEN cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
RGEN cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -45000000.00
RGEN cash_flow (annual, 2022-12-31) — Purchase Of Investment: -100000000.00
RGEN cash_flow (annual, 2022-12-31) — Purchase Of PPE: -84834000.00
RGEN balance_sheet (annual, 2022-12-31) — Raw Materials: 149438000.00
RGEN balance_sheet (annual, 2022-12-31) — Receivables: 116247000.00
RGEN income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 345830000.00
RGEN income_statement (annual, 2022-12-31) — Reconciled Depreciation: 57012000.00
RGEN cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
RGEN cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
RGEN income_statement (annual, 2022-12-31) — Research And Development: 43936000.00
RGEN income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: -28729000.00
RGEN balance_sheet (annual, 2022-12-31) — Retained Earnings: 397272000.00
RGEN cash_flow (annual, 2022-12-31) — Sale Of Investment: 0.00
RGEN income_statement (annual, 2022-12-31) — Selling General And Administration: 215829000.00
RGEN balance_sheet (annual, 2022-12-31) — Share Issued: 55557698.00
RGEN income_statement (annual, 2022-12-31) — Special Income Charges: 28729000.00
RGEN cash_flow (annual, 2022-12-31) — Stock Based Compensation: 27316000.00
RGEN balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1910700000.00
RGEN balance_sheet (annual, 2022-12-31) — Tangible Book Value: 694569000.00
RGEN income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 5391757.00
RGEN income_statement (annual, 2022-12-31) — Tax Provision: 33181000.00
RGEN income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.15
RGEN balance_sheet (annual, 2022-12-31) — Total Assets: 2531600000.00
RGEN balance_sheet (annual, 2022-12-31) — Total Capitalization: 1910700000.00
RGEN balance_sheet (annual, 2022-12-31) — Total Debt: 422961000.00
RGEN balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1910700000.00
RGEN income_statement (annual, 2022-12-31) — Total Expenses: 605595000.00
RGEN balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 620900000.00
RGEN balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1533482000.00
RGEN balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 216704000.00
RGEN income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 224670000.00
RGEN income_statement (annual, 2022-12-31) — Total Other Finance Cost: 1815000.00
RGEN balance_sheet (annual, 2022-12-31) — Total Tax Payable: 2459000.00
RGEN income_statement (annual, 2022-12-31) — Total Unusual Items: 35707000.00
RGEN income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 35707000.00
RGEN balance_sheet (annual, 2022-12-31) — Work In Process: 6183000.00
RGEN balance_sheet (annual, 2022-12-31) — Working Capital: 593922000.00
RGEN income_statement (annual, 2023-12-31) — +Operating Expense: 261306000.00
RGEN income_statement (annual, 2023-12-31) — +Total Revenue: 632362000.00
RGEN balance_sheet (annual, 2023-12-31) — Accounts Payable: 19563000.00
RGEN balance_sheet (annual, 2023-12-31) — Accounts Receivable: 124161000.00
RGEN balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -128723000.00
RGEN balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1569227000.00
RGEN balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -2122000.00
RGEN income_statement (annual, 2023-12-31) — Basic Average Shares: 55719860.00
RGEN income_statement (annual, 2023-12-31) — Basic EPS: 0.75
RGEN cash_flow (annual, 2023-12-31) — Beginning Cash Position: 523458000.00
RGEN balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 1667000.00
RGEN cash_flow (annual, 2023-12-31) — Capital Expenditure: -38988000.00
RGEN cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -2766000.00
RGEN balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 132209000.00
RGEN balance_sheet (annual, 2023-12-31) — Capital Stock: 558000.00
RGEN balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 751323000.00
RGEN balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 751323000.00
RGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 248961000.00
RGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -123275000.00
RGEN cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 113918000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Account Payable: -9803000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -21518000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Inventory: 40973000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -461000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -12641000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Payable: -9803000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -31321000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -13333000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Receivables: -3312000.00
RGEN cash_flow (annual, 2023-12-31) — Change In Working Capital: -20095000.00
RGEN cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -3312000.00
RGEN cash_flow (annual, 2023-12-31) — Changes In Cash: 239604000.00
RGEN balance_sheet (annual, 2023-12-31) — Common Stock: 558000.00
RGEN balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1964845000.00
RGEN cash_flow (annual, 2023-12-31) — Common Stock Payments: -14386000.00
RGEN balance_sheet (annual, 2023-12-31) — Construction In Progress: 47086000.00
RGEN income_statement (annual, 2023-12-31) — Cost Of Revenue: 353922000.00
RGEN balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 16772000.00
RGEN balance_sheet (annual, 2023-12-31) — Current Assets: 1111346000.00
RGEN balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 5631000.00
RGEN balance_sheet (annual, 2023-12-31) — Current Debt: 69452000.00
RGEN balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 75083000.00
RGEN balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 17067000.00
RGEN balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 17067000.00
RGEN balance_sheet (annual, 2023-12-31) — Current Liabilities: 164942000.00
RGEN cash_flow (annual, 2023-12-31) — Deferred Income Tax: 1175000.00
RGEN cash_flow (annual, 2023-12-31) — Deferred Tax: 1175000.00
RGEN cash_flow (annual, 2023-12-31) — Depreciation: 86114000.00
RGEN cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 86114000.00
RGEN cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 86114000.00
RGEN income_statement (annual, 2023-12-31) — Diluted Average Shares: 56377319.00
RGEN income_statement (annual, 2023-12-31) — Diluted EPS: 0.74
RGEN income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 35596000.00
RGEN income_statement (annual, 2023-12-31) — EBIT: 59210000.00
RGEN income_statement (annual, 2023-12-31) — EBITDA: 145324000.00
RGEN cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -11739000.00
RGEN cash_flow (annual, 2023-12-31) — End Cash Position: 751323000.00
RGEN cash_flow (annual, 2023-12-31) — Financing Cash Flow: 248961000.00
RGEN balance_sheet (annual, 2023-12-31) — Finished Goods: 74231000.00
RGEN cash_flow (annual, 2023-12-31) — Free Cash Flow: 74930000.00
RGEN cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 0.00
RGEN income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 24135000.00
RGEN balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -37808000.00
RGEN balance_sheet (annual, 2023-12-31) — Goodwill: 987120000.00
RGEN balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 1394077000.00
RGEN balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 126283000.00
RGEN balance_sheet (annual, 2023-12-31) — Gross PPE: 451678000.00
RGEN income_statement (annual, 2023-12-31) — Gross Profit: 278440000.00
RGEN cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 26963000.00
RGEN balance_sheet (annual, 2023-12-31) — Income Tax Payable: 6814000.00
RGEN income_statement (annual, 2023-12-31) — Interest Expense: 2503000.00
RGEN income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2503000.00
RGEN cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 988000.00
RGEN balance_sheet (annual, 2023-12-31) — Inventory: 202321000.00
RGEN balance_sheet (annual, 2023-12-31) — Invested Capital: 2544440000.00
RGEN cash_flow (annual, 2023-12-31) — Investing Cash Flow: -123275000.00
RGEN cash_flow (annual, 2023-12-31) — Issuance Of Debt: 290094000.00
RGEN balance_sheet (annual, 2023-12-31) — Land And Improvements: 992000.00
RGEN balance_sheet (annual, 2023-12-31) — Leases: 126663000.00
RGEN balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 126578000.00
RGEN balance_sheet (annual, 2023-12-31) — Long Term Debt: 510143000.00
RGEN balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 636721000.00
RGEN cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 290094000.00
RGEN cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
RGEN balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 44605000.00
RGEN cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -186642000.00
RGEN cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -14386000.00
RGEN income_statement (annual, 2023-12-31) — Net Income: 35596000.00
RGEN income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 35596000.00
RGEN income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 35596000.00
RGEN income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 35596000.00
RGEN income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 35596000.00
RGEN cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 35596000.00
RGEN income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 35596000.00
RGEN cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: 0.00
RGEN income_statement (annual, 2023-12-31) — Net Interest Income: -10578000.00
RGEN cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 102323000.00
RGEN cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 290094000.00
RGEN cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 290094000.00
RGEN income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -10578000.00
RGEN cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -27823000.00
RGEN cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 32000.00
RGEN balance_sheet (annual, 2023-12-31) — Net PPE: 322955000.00
RGEN cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -36222000.00
RGEN balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 570768000.00
RGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 1530000.00
RGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 39324000.00
RGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 1530000.00
RGEN balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 39324000.00
RGEN income_statement (annual, 2023-12-31) — Normalized EBITDA: 103296000.00
RGEN income_statement (annual, 2023-12-31) — Normalized Income: 9202416.00
RGEN cash_flow (annual, 2023-12-31) — Operating Cash Flow: 113918000.00
RGEN cash_flow (annual, 2023-12-31) — Operating Gains Losses: 12676000.00
RGEN income_statement (annual, 2023-12-31) — Operating Income: 17134000.00
RGEN income_statement (annual, 2023-12-31) — Operating Revenue: 632362000.00
RGEN balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 55766078.00
RGEN balance_sheet (annual, 2023-12-31) — Other Current Assets: 19922000.00
RGEN balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 69452000.00
RGEN balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 12983000.00
RGEN balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -37808000.00
RGEN income_statement (annual, 2023-12-31) — Other Income Expense: 50151000.00
RGEN balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 406957000.00
RGEN cash_flow (annual, 2023-12-31) — Other Non Cash Items: -27123000.00
RGEN balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1277000.00
RGEN balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 25353000.00
RGEN income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 8123000.00
RGEN balance_sheet (annual, 2023-12-31) — Other Properties: 230665000.00
RGEN balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
RGEN income_statement (annual, 2023-12-31) — Other Special Charges: 12676000.00
RGEN balance_sheet (annual, 2023-12-31) — Payables: 26377000.00
RGEN balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 43149000.00
RGEN balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 16660000.00
RGEN balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
RGEN balance_sheet (annual, 2023-12-31) — Prepaid Assets: 13619000.00
RGEN income_statement (annual, 2023-12-31) — Pretax Income: 56707000.00
RGEN cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1076000.00
RGEN balance_sheet (annual, 2023-12-31) — Properties: 0.00
RGEN cash_flow (annual, 2023-12-31) — Purchase Of Business: -186642000.00
RGEN cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: 0.00
RGEN cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
RGEN cash_flow (annual, 2023-12-31) — Purchase Of PPE: -36222000.00
RGEN balance_sheet (annual, 2023-12-31) — Raw Materials: 123598000.00
RGEN balance_sheet (annual, 2023-12-31) — Receivables: 124161000.00
RGEN income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 353922000.00
RGEN income_statement (annual, 2023-12-31) — Reconciled Depreciation: 86114000.00
RGEN cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
RGEN cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -14386000.00
RGEN income_statement (annual, 2023-12-31) — Research And Development: 42722000.00
RGEN income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -30569000.00
RGEN balance_sheet (annual, 2023-12-31) — Retained Earnings: 432868000.00
RGEN cash_flow (annual, 2023-12-31) — Sale Of Investment: 102323000.00
RGEN cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
RGEN income_statement (annual, 2023-12-31) — Selling General And Administration: 218584000.00
RGEN balance_sheet (annual, 2023-12-31) — Share Issued: 55766078.00
RGEN income_statement (annual, 2023-12-31) — Special Income Charges: 17893000.00
RGEN cash_flow (annual, 2023-12-31) — Stock Based Compensation: 25575000.00
RGEN balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1964845000.00
RGEN balance_sheet (annual, 2023-12-31) — Tangible Book Value: 570768000.00
RGEN income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 15634416.00
RGEN income_statement (annual, 2023-12-31) — Tax Provision: 21111000.00
RGEN income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.37
RGEN balance_sheet (annual, 2023-12-31) — Total Assets: 2831185000.00
RGEN balance_sheet (annual, 2023-12-31) — Total Capitalization: 2474988000.00
RGEN balance_sheet (annual, 2023-12-31) — Total Debt: 711804000.00
RGEN balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1964845000.00
RGEN income_statement (annual, 2023-12-31) — Total Expenses: 615228000.00
RGEN balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 866340000.00
RGEN balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1719839000.00
RGEN balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 701398000.00
RGEN income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 47703000.00
RGEN income_statement (annual, 2023-12-31) — Total Other Finance Cost: 8075000.00
RGEN balance_sheet (annual, 2023-12-31) — Total Tax Payable: 6814000.00
RGEN income_statement (annual, 2023-12-31) — Total Unusual Items: 42028000.00
RGEN income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 42028000.00
RGEN balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
RGEN balance_sheet (annual, 2023-12-31) — Work In Process: 4492000.00
RGEN balance_sheet (annual, 2023-12-31) — Working Capital: 946404000.00
RGEN cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
RGEN cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
RGEN income_statement (annual, 2024-12-31) — +Operating Expense: 306568000.00
RGEN income_statement (annual, 2024-12-31) — +Total Revenue: 634439000.00
RGEN balance_sheet (annual, 2024-12-31) — Accounts Payable: 32134000.00
RGEN balance_sheet (annual, 2024-12-31) — Accounts Receivable: 134115000.00
RGEN balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -162467000.00
RGEN balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -162467000.00
RGEN balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 1617336000.00
RGEN balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1832000.00
RGEN income_statement (annual, 2024-12-31) — Basic Average Shares: 55936751.00
RGEN income_statement (annual, 2024-12-31) — Basic EPS: -0.46
RGEN cash_flow (annual, 2024-12-31) — Beginning Cash Position: 751323000.00
RGEN balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 675000.00
RGEN balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 675000.00
RGEN cash_flow (annual, 2024-12-31) — Capital Expenditure: -32905000.00
RGEN cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -4222000.00
RGEN balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 160680000.00
RGEN balance_sheet (annual, 2024-12-31) — Capital Stock: 561000.00
RGEN balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 757355000.00
RGEN balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 757355000.00
RGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -82902000.00
RGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -86383000.00
RGEN cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 175394000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Account Payable: 12898000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 6106000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Inventory: 56895000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 471000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -2971000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Payable: 12898000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 19004000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1553000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Receivables: -14031000.00
RGEN cash_flow (annual, 2024-12-31) — Change In Working Capital: 60921000.00
RGEN cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -14031000.00
RGEN cash_flow (annual, 2024-12-31) — Changes In Cash: 6109000.00
RGEN balance_sheet (annual, 2024-12-31) — Common Stock: 561000.00
RGEN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1972718000.00
RGEN cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
RGEN balance_sheet (annual, 2024-12-31) — Construction In Progress: 28211000.00
RGEN balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 28211000.00
RGEN income_statement (annual, 2024-12-31) — Cost Of Revenue: 359794000.00
RGEN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 15594000.00
RGEN balance_sheet (annual, 2024-12-31) — Current Assets: 1066041000.00
RGEN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 15104000.00
RGEN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 15104000.00
RGEN balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 13243000.00
RGEN balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 13243000.00
RGEN balance_sheet (annual, 2024-12-31) — Current Liabilities: 126787000.00
RGEN cash_flow (annual, 2024-12-31) — Deferred Income Tax: -16790000.00
RGEN cash_flow (annual, 2024-12-31) — Deferred Tax: -16790000.00
RGEN cash_flow (annual, 2024-12-31) — Depreciation: 86562000.00
RGEN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 86562000.00
RGEN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 86562000.00
RGEN income_statement (annual, 2024-12-31) — Diluted Average Shares: 55936751.00
RGEN income_statement (annual, 2024-12-31) — Diluted EPS: -0.46
RGEN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -25514000.00
RGEN income_statement (annual, 2024-12-31) — EBIT: -6304000.00
RGEN income_statement (annual, 2024-12-31) — EBITDA: 80258000.00
RGEN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -77000.00
RGEN cash_flow (annual, 2024-12-31) — End Cash Position: 757355000.00
RGEN cash_flow (annual, 2024-12-31) — Financing Cash Flow: -82902000.00
RGEN balance_sheet (annual, 2024-12-31) — Finished Goods: 56214000.00
RGEN cash_flow (annual, 2024-12-31) — Free Cash Flow: 142489000.00
RGEN cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 3596000.00
RGEN income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 35827000.00
RGEN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -52533000.00
RGEN balance_sheet (annual, 2024-12-31) — Goodwill: 1030995000.00
RGEN balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1428892000.00
RGEN balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 135947000.00
RGEN balance_sheet (annual, 2024-12-31) — Gross PPE: 495583000.00
RGEN income_statement (annual, 2024-12-31) — Gross Profit: 274645000.00
RGEN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 19298000.00
RGEN balance_sheet (annual, 2024-12-31) — Income Tax Payable: 1423000.00
RGEN income_statement (annual, 2024-12-31) — Interest Expense: 20731000.00
RGEN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 20731000.00
RGEN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 6070000.00
RGEN balance_sheet (annual, 2024-12-31) — Inventory: 142964000.00
RGEN balance_sheet (annual, 2024-12-31) — Invested Capital: 2498285000.00
RGEN cash_flow (annual, 2024-12-31) — Investing Cash Flow: -86383000.00
RGEN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
RGEN balance_sheet (annual, 2024-12-31) — Land And Improvements: 824000.00
RGEN balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 824000.00
RGEN balance_sheet (annual, 2024-12-31) — Leases: 145256000.00
RGEN balance_sheet (quarterly, 2024-12-31) — Leases: 145256000.00
RGEN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 145576000.00
RGEN balance_sheet (annual, 2024-12-31) — Long Term Debt: 525567000.00
RGEN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 671143000.00
RGEN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
RGEN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -69939000.00
RGEN cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: 0.00
RGEN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 54322000.00
RGEN balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 54322000.00
RGEN cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -54765000.00
RGEN cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
RGEN income_statement (annual, 2024-12-31) — Net Income: -25514000.00
RGEN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -25514000.00
RGEN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -25514000.00
RGEN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -25514000.00
RGEN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -25514000.00
RGEN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -25514000.00
RGEN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -25514000.00
RGEN cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -3006000.00
RGEN income_statement (annual, 2024-12-31) — Net Interest Income: -22574000.00
RGEN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
RGEN cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
RGEN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -69939000.00
RGEN cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
RGEN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -69939000.00
RGEN cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
RGEN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -22574000.00
RGEN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -17257000.00
RGEN cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 1287000.00
RGEN balance_sheet (annual, 2024-12-31) — Net PPE: 333116000.00
RGEN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -25677000.00
RGEN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 543826000.00
RGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 749000.00
RGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 22775000.00
RGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 749000.00
RGEN balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 22775000.00
RGEN income_statement (annual, 2024-12-31) — Normalized EBITDA: 47622000.00
RGEN income_statement (annual, 2024-12-31) — Normalized Income: -56322384.00
RGEN cash_flow (annual, 2024-12-31) — Operating Cash Flow: 175394000.00
RGEN cash_flow (annual, 2024-12-31) — Operating Gains Losses: 3596000.00
RGEN income_statement (annual, 2024-12-31) — Operating Income: -31923000.00
RGEN income_statement (annual, 2024-12-31) — Operating Revenue: 634439000.00
RGEN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 56091677.00
RGEN balance_sheet (annual, 2024-12-31) — Other Current Assets: 20597000.00
RGEN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 17126000.00
RGEN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -52533000.00
RGEN income_statement (annual, 2024-12-31) — Other Income Expense: 27462000.00
RGEN balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 397897000.00
RGEN cash_flow (annual, 2024-12-31) — Other Non Cash Items: 22145000.00
RGEN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 868000.00
RGEN balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 36243000.00
RGEN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -5174000.00
RGEN balance_sheet (annual, 2024-12-31) — Other Properties: 266295000.00
RGEN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 0.00
RGEN balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 0.00
RGEN balance_sheet (annual, 2024-12-31) — Payables: 33557000.00
RGEN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 49151000.00
RGEN balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 32163000.00
RGEN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
RGEN balance_sheet (annual, 2024-12-31) — Prepaid Assets: 11010000.00
RGEN balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 11010000.00
RGEN income_statement (annual, 2024-12-31) — Pretax Income: -27035000.00
RGEN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 4294000.00
RGEN balance_sheet (annual, 2024-12-31) — Properties: 0.00
RGEN balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
RGEN cash_flow (annual, 2024-12-31) — Purchase Of Business: -54765000.00
RGEN cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -3006000.00
RGEN cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
RGEN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -25677000.00
RGEN balance_sheet (annual, 2024-12-31) — Raw Materials: 82208000.00
RGEN balance_sheet (annual, 2024-12-31) — Receivables: 134115000.00
RGEN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 359794000.00
RGEN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 86562000.00
RGEN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -69939000.00
RGEN cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: 0.00
RGEN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
RGEN income_statement (annual, 2024-12-31) — Research And Development: 43200000.00
RGEN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 3191000.00
RGEN balance_sheet (annual, 2024-12-31) — Retained Earnings: 407354000.00
RGEN cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
RGEN cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
RGEN cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
RGEN income_statement (annual, 2024-12-31) — Selling General And Administration: 263368000.00
RGEN balance_sheet (annual, 2024-12-31) — Share Issued: 56091677.00
RGEN income_statement (annual, 2024-12-31) — Special Income Charges: -3191000.00
RGEN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 48070000.00
RGEN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1972718000.00
RGEN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 543826000.00
RGEN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 1827616.00
RGEN income_statement (annual, 2024-12-31) — Tax Provision: -1521000.00
RGEN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.06
RGEN balance_sheet (annual, 2024-12-31) — Total Assets: 2829666000.00
RGEN balance_sheet (annual, 2024-12-31) — Total Capitalization: 2498285000.00
RGEN balance_sheet (annual, 2024-12-31) — Total Debt: 686247000.00
RGEN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1972718000.00
RGEN income_statement (annual, 2024-12-31) — Total Expenses: 666362000.00
RGEN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 856948000.00
RGEN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1763625000.00
RGEN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 730161000.00
RGEN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -35114000.00
RGEN income_statement (annual, 2024-12-31) — Total Other Finance Cost: 1843000.00
RGEN balance_sheet (annual, 2024-12-31) — Total Tax Payable: 1423000.00
RGEN income_statement (annual, 2024-12-31) — Total Unusual Items: 32636000.00
RGEN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 32636000.00
RGEN balance_sheet (annual, 2024-12-31) — Work In Process: 4542000.00
RGEN balance_sheet (annual, 2024-12-31) — Working Capital: 939254000.00
RGEN income_statement (quarterly, 2025-03-31) — +Operating Expense: 82820000.00
RGEN income_statement (quarterly, 2025-03-31) — +Total Revenue: 169172000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 26935000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 147413000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -171948000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1619578000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -2113000.00
RGEN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 56122742.00
RGEN income_statement (quarterly, 2025-03-31) — Basic EPS: 0.10
RGEN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 757355000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 703000.00
RGEN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -4430000.00
RGEN cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -867000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 154093000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 562000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 697229000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 697229000.00
RGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -5030000.00
RGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -74108000.00
RGEN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 15005000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -6693000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1807000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Inventory: -3828000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -1202000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -4361000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Payable: -6693000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -4886000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -2191000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Receivables: -9921000.00
RGEN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -26389000.00
RGEN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -9921000.00
RGEN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -64133000.00
RGEN balance_sheet (quarterly, 2025-03-31) — Common Stock: 562000.00